Table 4.

Mode of actions, application and 2D structure of shortlisted top five docked drugs with high binding affinity for each target. The mode of actions, applications was collected from DrugBank, Inxight Drugs portal and PubChem database.

Target	Drug	PDID	Drug Status	Primary Indications (1. Mode of Action; 2. Treatment)	2D Structure
I7L	Eluxadoline	PD008978	Approved	1.An agonist of mixed mu-opioid receptor.
				2.Used for the treatment of irritable bowel syndrome with diarrhea.
I7L, VETFS	Burixafor	PD058763	Investigational	1.Inhibitor of CXC chemokine receptor 4 (CXCR4)
				2.Used in trials studying treatment of Hodgkin's disease, Non-hodgkin's Lymphoma and Multiple Myeloma.
I7L	Cefotiam	PD010157	Approved	1.Inhibits the bacterial cell wall biosynthesis.
				2. Used for the treating a myriad of bacterial infections.
I7L	Tobramycin	PD001728	Approved	1.Inhibits the synthesis of protein by binding to ribosome 30S subunit in bacterial cells.
				2.Used for the treating a myriad of bacterial infections.
I7L	Danegaptide	PD058923	Investigational	1.A selective 2nd generation gap junction modifier in adjacent cardiomyocytes.
				2.Used in studying treatment of chronic atrial fibrillation (AF) and postoperative AF in large animal models.
Top1B	Carbaphosphonate	PD059915	Investigational	1.3-dehydroquinate synthase inhibitor (Staphylococcus aureus)
Top1B	α-d-galacturonic acid	PD006851	Investigational	1.Backbone of pectin, cellular binders in the peel of many different fruits and vegetables.
				2.Used as: antidiarrheal drug, food emulsifier, food stabilizer, food thickening agent and food gelling agent.
Top1B	Adenosine phosphonoacetic acid	PD059913	Investigational	1.ndp kinase (human) inhibitor.
Top1B	Guanosine-2′,3′-O-methylidenephosphonate	PD006419	Investigational	1.catalyze the phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy) ribonucleoside molecules
Top1B	Deferitazole	PD058219	Investigational	1.An iron cheater
				2.Used in trials studying the treatment and basic science of Beta-thalassemia.
VETFS	DB02785	PD059991	Investigational	1.Gag-Pol polyprotein inhibitor
				2.Used as an antiviral (antiHIV-1)
VETFS	Radezolid	PD012727	Investigational	1.A 2nd generation's oxazolidinone antibiotic, inhibits the RRBP1.
				2.Used in trials for studying the treatment of Abscess, Infectious Skin Diseases.
VETFS	Rapastinel	PD070040	Investigational	1.NMDA receptor modulator with glycine-site partial agonist properties.
				2.Used in trials studying the treatment of Major and Obsessive-Compulsive Disorder (OCD).
I7L, A20R	Batefenterol	PD058591	Investigational	1.A bifunctional muscarinic (M2 and M3 receptors) antagonist and β2-agonist
				2.Used in trials for studying the treatment of Chronic Obstructive Pulmonary Disorder (COPD).
A20R	Nebivolol	PD009358	Approved	1.β-1 adrenergic receptor antagonist (beta blockers).
				2.Used to treat high blood pressure either alone or in combination with other medications.
A20R	Pimozide	PD001879	Approved	1.Dopamine type 2 receptors blocker
				2.Used to control motor or verbal tics caused by Tourette's disorder.
A20R	BAZ2-ICR	PD046767	Investigational	1.Epithelial sodium channel blocker
				2.Used in trials for studying cystic fibrosis and chronic bronchitis.
A20R	PF-610355	PD058896	Investigational	1.A novel Ultra-Long-Acting β2-Adrenoreceptor agonist.
				2.Used for studying the treatment of Asthma and Chronic Obstructive Pulmonary Disease.